📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5. (2017)

First Author: Al-Jameel W

Attributed to: University of Liverpool Confidence in Concept Program – Enhancing Translation funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.18632/oncotarget.16055

PubMed Identifier: 28415688

Publication URI: http://europepmc.org/abstract/MED/28415688

Type: Journal Article/Review

Volume: 8

Parent Publication: Oncotarget

Issue: 19

ISSN: 1949-2553